» Articles » PMID: 34837505

Interpreting Global Trends in Type 2 Diabetes Complications and Mortality

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2021 Nov 27
PMID 34837505
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

International trends in traditional diabetes complications (cardiovascular, renal, peripheral vascular, ophthalmic, hepatic or neurological diseases) and mortality rates are poorly characterised. An earlier review of studies published up to 2015 demonstrated that most data come from a dozen high-income countries (HICs) in North America, Europe or the Asia-Pacific region and that, in these countries at least, rates of acute glycaemic fluctuations needing medical attention and amputations, myocardial infarction and mortality were all declining over the period. Here, we provide an updated review of published literature on trends in type 2 diabetes complications and mortality in adults since 2015. We also discuss issues related to data collection, analysis and reporting that have influenced global trends in type 2 diabetes and its complications. We found that most data on trends in type 2 diabetes, its complications and mortality come from a small number of HICs with comprehensive surveillance systems, though at least some low- and middle-income countries (LMICs) from Africa and Latin America are represented in this review. The published data suggest that HICs have experienced declines in cardiovascular complication rates and all-cause mortality in people with diabetes. In parallel, cardiovascular complications and mortality rates in people with diabetes have increased over time in LMICs. However, caution is warranted in interpreting trends from LMICs due to extremely sparse data or data that are not comparable across countries. We noted that approaches to case ascertainment and definitions of complications and mortality (numerators) and type 2 diabetes (the denominator) vary widely and influence the interpretation of international data. We offer four key recommendations to more rigorously document trends in rates of type 2 diabetes complications and mortality, over time and worldwide: (1) increasing investments in data collection systems; (2) standardising case definitions and approaches to ascertainment; (3) strengthening analytical capacity; and (4) developing and implementing structured guidelines for reporting of data.

Citing Articles

Risk factors for osteoporosis in elderly patients with type 2 diabetes: A protocol for systematic review and meta-analysis.

Su W, Jia H, Yang L, Zhang J, Wei Z, Tsikwa P PLoS One. 2025; 20(2):e0319602.

PMID: 40014597 PMC: 11867315. DOI: 10.1371/journal.pone.0319602.


Ignored or underestimated - evaluation and treatment of cardiovascular risk factors in patients with adrenal insufficiency.

Wasmuth A, van de Loo I, Domberg J, Harbeck B Endocrine. 2025; .

PMID: 40000548 DOI: 10.1007/s12020-025-04192-0.


Association between diabetes of different durations and hip fracture in middle-aged and older people: a stratified cohort study from CHARLS 2011-2020.

Chang Y, Huang Y, Li R, Gui L BMC Public Health. 2025; 25(1):691.

PMID: 39972262 PMC: 11841281. DOI: 10.1186/s12889-025-21923-0.


Associations of MAFLD subtypes and air pollutants with multi-system morbidity and all-cause mortality: A prospective cohort study.

Zhang J, Ran S, Wei S, Tian F, Chen L, Yang Z Ecotoxicol Environ Saf. 2025; 291:117893.

PMID: 39955868 PMC: 11860302. DOI: 10.1016/j.ecoenv.2025.117893.


Global, regional, and national burden of type 2 diabetes mellitus caused by high BMI from 1990 to 2021, and forecasts to 2045: analysis from the global burden of disease study 2021.

Huang X, Wu Y, Ni Y, Xu H, He Y Front Public Health. 2025; 13:1515797.

PMID: 39916706 PMC: 11798972. DOI: 10.3389/fpubh.2025.1515797.


References
1.
Selvin E, Wang D, Matsushita K, Grams M, Coresh J . Prognostic Implications of Single-Sample Confirmatory Testing for Undiagnosed Diabetes: A Prospective Cohort Study. Ann Intern Med. 2018; 169(3):156-164. PMC: 6082697. DOI: 10.7326/M18-0091. View

2.
Gedebjerg A, Almdal T, Berencsi K, Rungby J, Nielsen J, Witte D . Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort. J Diabetes Complications. 2017; 32(1):34-40. DOI: 10.1016/j.jdiacomp.2017.09.010. View

3.
Chaparro-Narvaez P, Alvis-Zakzuk N, Diaz-Jimenez D, Castaneda-Orjuela C . Trends in diabetes mortality identified from death certificates in Colombia, 1979-2017. Rev Panam Salud Publica. 2021; 45:e13. PMC: 7815170. DOI: 10.26633/RPSP.2021.13. View

4.
Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter M, Ezzati M . Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol. 2018; 6(6):e6-e15. PMC: 5982644. DOI: 10.1016/S2213-8587(18)30150-5. View

5.
Fang M, Selvin E . Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes. Diabetes Care. 2021; 44(3):699-706. PMC: 7896270. DOI: 10.2337/dc20-2304. View